Kurt Schönfeld

2.3k total citations
19 papers, 1.6k citations indexed

About

Kurt Schönfeld is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Kurt Schönfeld has authored 19 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Kurt Schönfeld's work include Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (6 papers). Kurt Schönfeld is often cited by papers focused on Immune Cell Function and Interaction (7 papers), CAR-T cell therapy research (6 papers) and Immunotherapy and Immune Responses (6 papers). Kurt Schönfeld collaborates with scholars based in Germany, United States and Sweden. Kurt Schönfeld's co-authors include Winfried S. Wels, Torsten Tonn, Sabine Ring, Alexander Enk, Theron Johnson, Karsten Mahnke, Tanja Bedke, Sonja Schallenberg, Patrick N. Harter and Michael C. Burger and has published in prestigious journals such as Blood, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Kurt Schönfeld

18 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kurt Schönfeld Germany 11 1.1k 969 369 267 249 19 1.6k
Leslie E. Huye United States 19 1.0k 0.9× 663 0.7× 615 1.7× 425 1.6× 175 0.7× 28 1.7k
Michael Klichinsky United States 14 1.3k 1.2× 902 0.9× 586 1.6× 327 1.2× 315 1.3× 56 2.0k
Blythe Sather United States 19 733 0.6× 1.1k 1.2× 671 1.8× 442 1.7× 135 0.5× 29 2.0k
Hiroki Torikai United States 17 957 0.8× 634 0.7× 577 1.6× 452 1.7× 235 0.9× 32 1.4k
Harvey A. Greisman United States 14 889 0.8× 444 0.5× 859 2.3× 385 1.4× 208 0.8× 22 1.8k
Linjie Guo United States 13 930 0.8× 749 0.8× 348 0.9× 248 0.9× 193 0.8× 24 1.4k
Elena Sotillo United States 22 1.6k 1.4× 588 0.6× 980 2.7× 396 1.5× 491 2.0× 45 2.3k
Bianca von Scheidt Australia 16 918 0.8× 938 1.0× 215 0.6× 103 0.4× 140 0.6× 21 1.3k
Franziska Blaeschke Germany 18 832 0.7× 449 0.5× 658 1.8× 288 1.1× 165 0.7× 33 1.4k
Christine L. Wright United States 13 1.2k 1.1× 674 0.7× 398 1.1× 403 1.5× 439 1.8× 21 1.7k

Countries citing papers authored by Kurt Schönfeld

Since Specialization
Citations

This map shows the geographic impact of Kurt Schönfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Schönfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Schönfeld more than expected).

Fields of papers citing papers by Kurt Schönfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Schönfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Schönfeld. The network helps show where Kurt Schönfeld may publish in the future.

Co-authorship network of co-authors of Kurt Schönfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Kurt Schönfeld. A scholar is included among the top collaborators of Kurt Schönfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kurt Schönfeld. Kurt Schönfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Schönfeld, Kurt, et al.. (2018). Activity of Indatuximab Ravtansine against Triple-Negative Breast Cancer in Preclinical Tumor Models. Pharmaceutical Research. 35(6). 118–118. 19 indexed citations
2.
Schönfeld, Kurt, et al.. (2018). Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate. PLoS ONE. 13(4). e0195823–e0195823. 21 indexed citations
3.
Zhang, Congcong, Michael C. Burger, Lukas Jennewein, et al.. (2015). ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma. JNCI Journal of the National Cancer Institute. 108(5). 315 indexed citations
4.
Minckwitz, Gϋnter von, Berit M. Pfitzner, Volkmar Müller, et al.. (2015). Expression of CD138 / syndecan-1 in triple-negative breast cancer – correlative study of GeparSixto. Annals of Oncology. 26. iii6–iii6. 1 indexed citations
5.
Grabski, Elena, Frank Klawonn, Marius Döring, et al.. (2015). Antibody induced CD4 down-modulation of T cells is site-specifically mediated by CD64+ cells. Scientific Reports. 5(1). 18308–18308. 4 indexed citations
6.
Burger, Michael C., Lukas Jennewein, Kurt Schönfeld, et al.. (2014). ERBB2/HER2-SPECIFIC NATURAL KILLER CELLS FOR ADOPTIVE IMMUNOTHERAPY OF GLIOBLASTOMA. Neuro-Oncology. 16(suppl 3). iii44–iii44. 2 indexed citations
7.
Grada, Zakaria, Meenakshi Hegde, Tiara T. Byrd, et al.. (2013). TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy. Molecular Therapy — Nucleic Acids. 2. e105–e105. 378 indexed citations
8.
Schönfeld, Kurt, et al.. (2012). Expression of IL-15 in NK cells results in rapid enrichment and selective cytotoxicity of gene-modified effectors that carry a tumor-specific antigen receptor. Cancer Immunology Immunotherapy. 61(9). 1451–1461. 157 indexed citations
9.
Zhou, Qi, Irene C. Schneider, Annemarie Honegger, et al.. (2012). T-cell receptor gene transfer exclusively to human CD8+ cells enhances tumor cell killing. Blood. 120(22). 4334–4342. 55 indexed citations
10.
Esser, Ruth, Tina Müller, Stephan Kloeß, et al.. (2011). NK cells engineered to express a GD2‐specific antigen receptor display built‐in ADCC‐like activity against tumour cells of neuroectodermal origin. Journal of Cellular and Molecular Medicine. 16(3). 569–581. 166 indexed citations
11.
Johnson, Theron, Karsten Mahnke, Kurt Schönfeld, et al.. (2008). Inhibition of Melanoma Growth by Targeting of Antigen to Dendritic Cells via an Anti-DEC-205 Single-Chain Fragment Variable Molecule. Clinical Cancer Research. 14(24). 8169–8177. 55 indexed citations
12.
Böller, Klaus, Kurt Schönfeld, Nicole Fischer, et al.. (2008). Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. Journal of General Virology. 89(2). 567–572. 101 indexed citations
13.
Mahnke, Karsten, Kurt Schönfeld, Sabine Ring, et al.. (2007). Depletion of CD4+CD25+ human regulatory T cells in vivo: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro. International Journal of Cancer. 120(12). 2723–2733. 187 indexed citations
14.
Mahnke, Karsten, Sabine Ring, Theron Johnson, et al.. (2007). Induction of immunosuppressive functions of dendritic cells in vivo by CD4+CD25+ regulatory T cells: Role of B7‐H3 expression and antigen presentation. European Journal of Immunology. 37(8). 2117–2126. 112 indexed citations
15.
Schönfeld, Kurt & Horst Zahner. (2000). Immunomodulatory effects in Litomosoides sigmodontis -infected Mastomys coucha. Parasitology Research. 86(2). 101–108. 2 indexed citations
16.
Schönfeld, Kurt, et al.. (1959). [Recent studies on hyalinosis cutis and mucosae].. PubMed. 38(6). 430–5. 1 indexed citations
17.
Schönfeld, Kurt. (1957). [Treatment of recent chemical burns & scaldings of the upper alimentary tract & their late sequelae in children].. PubMed. 105(10). 369–73. 1 indexed citations
18.
Schönfeld, Kurt. (1956). [Granuloma pyogenicum sive telangiectaticum in otorhinolaryngology].. PubMed. 35(4). 274–8. 1 indexed citations
19.
Schönfeld, Kurt. (1955). [The Camurati-Engelmann disease in a one and a half-year infant].. PubMed. 103(10). 451–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leslie E. Huye Breakdown of academic impact, for papers by Michael Klichinsky Breakdown of academic impact, for papers by Blythe Sather Breakdown of academic impact, for papers by Hiroki Torikai Breakdown of academic impact, for papers by Harvey A. Greisman Breakdown of academic impact, for papers by Linjie Guo Breakdown of academic impact, for papers by Elena Sotillo Breakdown of academic impact, for papers by Bianca von Scheidt Breakdown of academic impact, for papers by Franziska Blaeschke Breakdown of academic impact, for papers by Christine L. Wright
Rankless by CCL
2026